Effects of the partial agonist antipsychotic on dopamine synthesis capacity in human brain measured by PET with [C-11]DOPA

被引:0
|
作者
Ito, Hiroshi [1 ]
Takano, Harumasa [1 ]
Arakawa, Ryosuke [1 ]
Takahata, Keisuke [1 ]
Kodaka, Fumitoshi [1 ]
Takahashi, Hidehiko [1 ]
Suhara, Tetsuya [1 ]
机构
[1] Natl Inst Radiol Sci, Chiba 260, Japan
来源
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2012年 / 32卷
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S42 / S43
页数:2
相关论文
共 50 条
  • [41] Effect of Ulotaront on Brain Dopamine Synthesis Capacity in Subjects With Schizophrenia on Stable Doses of a D2 Antipsychotic: Results of an 18F-DOPA Pet Study
    Howes, Oliver
    Vano, Luke
    Rutigliano, Grazia
    McCutcheon, Robert
    Lew, Robert
    Milanovic, Snezana
    Lennek, Lisa
    Hopkins, Seth
    Koblan, Kenneth
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 : 387 - 388
  • [42] Quantitative analysis of dopamine synthesis in human brain using positron emission tomography with L-[β-11C]DOPA
    Ito, Hiroshi
    Ota, Miho
    Ikoma, Yoko
    Seki, Chie
    Yasuno, Furnihiko
    Takano, Akihiro
    Maeda, Jun
    Nakao, Ryuji
    Suzuki, Kazutoshi
    Suhara, Tetsuya
    NUCLEAR MEDICINE COMMUNICATIONS, 2006, 27 (09) : 723 - 731
  • [43] Quantification of dopamine synthesis in human brain using positron emission tomography with L-[beta-11C]DOPA
    Ito, Hiroshi
    Ota, M.
    Ikoma, Y.
    Maeda, J.
    Seki, C.
    Nozaki, S.
    Yasuno, F.
    Takano, A.
    Nakao, R.
    Suzuki, K.
    Suhara, T.
    NEUROIMAGE, 2006, 31 : T107 - T107
  • [44] STRIATAL DOPAMINE-D2 RECEPTORS IN PATIENTS WITH NARCOLEPSY MEASURED WITH POSITRON EMISSION TOMOGRAPHY (PET) AND C-11 RACLOPRIDE
    PARKES, D
    WEINDL, A
    MEIEREWERT, K
    DAHLITZ, M
    ANTONINI, A
    KHAN, N
    BEER, HF
    LEENDERS, KL
    NEUROLOGY, 1993, 43 (04) : A337 - A337
  • [45] Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [C-11]raclopride displacement and PET
    Tedroff, J
    Pedersen, M
    Aquilonius, SM
    Hartvig, P
    Jacobsson, G
    Langstrom, B
    NEUROLOGY, 1996, 46 (05) : 1430 - 1436
  • [46] Initial human PET imaging of dopamine D-1 receptors with D-1 agonist R-[C-11]SKF 82957.
    DaSilva, JN
    Schwartz, RA
    Wilson, AA
    Houle, S
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 71P - 71P
  • [47] Pharmacological regulation of dopamine synthesis capacity in human brain assessed with fdopa-PET.
    Gründer, G
    Vernaleken, I
    Buchholz, HG
    Müller, MJ
    Davids, E
    Munk, O
    Wong, DF
    Gjedde, A
    Bartenstein, P
    Cumming, P
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 17P - 17P
  • [48] [C-11] THYMIDINE PET IMAGING AS A MEASURE OF DNA-SYNTHESIS RATE - A PRELIMINARY QUANTITATIVE STUDY OF HUMAN BRAIN GLIOBLASTOMA
    WONG, CYO
    YUNG, BCY
    CONTI, P
    CHAN, B
    YUE, N
    HILTON, J
    ANDERSON, JH
    RAVERT, H
    HRUBAN, RH
    SCHEIDLER, V
    DANNALS, RF
    GROSSMAN, S
    BRYAN, RN
    WONG, DF
    JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (05) : P9 - P9
  • [49] Synthesis and in vivo evaluation of a C-11 labeled novel dopamine D1 receptor agonist radioligand in baboon
    Easwaramoorthy, Balu
    Neelamegam, Ramesh
    Palatnik, Matthew
    Myung, John
    Abi-Dargham, Anissa
    Slifstein, Mark
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [50] PET-characterization of [C-11]PE2I binding to dopamine transporter in the monkey brain.
    Halldin, C
    Guilloteau, D
    Okubo, Y
    Lundkvist, C
    Olsson, H
    Karlsson, P
    Chalon, S
    Emond, P
    Swahn, CG
    Farde, L
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 118P - 118P